During the past decade, MT Cancer Inst Fndtn; MT Can Spec conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "MT Cancer Inst Fndtn; MT Can Spec" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "MT Cancer Inst Fndtn; MT Can Spec" are "Lymphoma, B-Cell" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "MT Cancer Inst Fndtn; MT Can Spec" in a lesser frequency.

Most popular intervention types in "MT Cancer Inst Fndtn; MT Can Spec" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bendamustine" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials), "Obinutuzumab" (1 trials) and "Prednisone" (1 trials). Other intervention names were less common.

The vast majority of trials in "MT Cancer Inst Fndtn; MT Can Spec" are 2 trials for "All" genders.

Currently, there are NaN active trials in "MT Cancer Inst Fndtn; MT Can Spec". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MT Cancer Inst Fndtn; MT Can Spec, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MT Cancer Inst Fndtn; MT Can Spec, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".